Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trial
- 1 December 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (12), 1851-1853
- https://doi.org/10.1016/0277-5379(88)90097-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Effect of bromocriptin treatment on prolactin and steroid receptor levels in human breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- STIMULATION OF DNA-SYNTHESIS BY PROLACTIN IN HUMAN-BREAST TUMOR EXPLANTS - RELATION TO PROLACTIN RECEPTORS1984
- The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Prolactin receptors in human breast cancerEuropean Journal of Cancer and Clinical Oncology, 1982
- Evidence that Human Growth Hormone Is a Potent Lactogen in Primates*Journal of Clinical Endocrinology & Metabolism, 1980
- Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancerEuropean Journal of Cancer (1965), 1972